Importantly, TrialSite also reports the American market is at this point resoundingly rejecting the COVID-19 mRNA bivale...
Oct 5th 2022 9:44pm EDT
Importantly, TrialSite also reports the American market is at this point resoundingly rejecting the COVID-19 mRNA bivalent Omicron BA.4/BA.5 boosters as according to CDC data just four days ago only 3.6% of eligible participants have opted to receive the booster dose. If there is a fall surge in SARS-CoV-2 cases, this could represent a real […]
Promote it on DissentWatch!
- To advertise this post for $0.02 per visit send bitcoins to the address below
- The post will be promoted daily via social media & our "Featured News" display in multiple places
- You can add more anytime
- Ranking order in the Featured News box is based on the balance remaining
Received: 0 mBTC (0.00 USD)
Spent: 0 mBTC (0.00 USD)
Balance: 0 mBTC (0.00 USD)
The amounts above may be lagging behind. If you just sent a payment click below to get more up to date results and push the post to the "Featured News" box faster.